210 related articles for article (PubMed ID: 16281375)
1. [Comparative efficacy and tolerability of paroxetine and amitriptiline in long-term therapy preventing depressive recurrences].
Mosolov SN; Kostiukova EG; Gorodnichev AV; Timofeev IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):22-9. PubMed ID: 16281375
[TBL] [Abstract][Full Text] [Related]
2. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline.
Pezzella G; Moslinger-Gehmayr R; Contu A
Breast Cancer Res Treat; 2001 Nov; 70(1):1-10. PubMed ID: 11766999
[TBL] [Abstract][Full Text] [Related]
3. Comparison of tolerance of venlafaxine, paroxetine and amitriptyline in depression therapy.
Miskovic M
Med Arch; 2015 Apr; 69(2):107-9. PubMed ID: 26005260
[TBL] [Abstract][Full Text] [Related]
4. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, multicentre study to assess the tolerability and efficacy of paroxetine compared with amitriptyline in the treatment of depressed patients in Australian general practice.
Freed E; Goldney R; Lambert T; Tiller J; Johnston R
Aust N Z J Psychiatry; 1999 Jun; 33(3):416-21. PubMed ID: 10442799
[TBL] [Abstract][Full Text] [Related]
6. [Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements].
Strobel M; Warnke A; Roth M; Schulze U
Z Kinder Jugendpsychiatr Psychother; 2004 Nov; 32(4):279-89. PubMed ID: 15565897
[TBL] [Abstract][Full Text] [Related]
7. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
Möslinger-Gehmayr R; Zaninelli R; Contu A; Oberhoff C; Gutschow K; Schindler AE; Staab HJ
Zentralbl Gynakol; 2000; 122(4):195-202. PubMed ID: 10795116
[TBL] [Abstract][Full Text] [Related]
8. Paroxetine in the treatment of generalised anxiety disorder.
Snyderman SH; Rynn MA; Bellew K; Rickels K
Expert Opin Pharmacother; 2004 Aug; 5(8):1799-806. PubMed ID: 15264994
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine in the treatment of Chinese patients with depressive episode: a double-blind randomized comparison with imipramine.
Chiu HJ; Hong CJ; Chan CH
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun; 57(6):418-23. PubMed ID: 8803304
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant treatment and global tests of coagulation and fibrinolysis.
Lederbogen F; Weber B; Colla M; Heuser I; Deuschle M; Dempfle CE
J Clin Psychiatry; 2001 Feb; 62(2):130. PubMed ID: 11247103
[No Abstract] [Full Text] [Related]
11. Platelet counts in depressed patients treated with amitriptyline or paroxetine.
Lederbogen F; Hörer E; Hellweg R; Heuser I; Deuschle M
Eur Psychiatry; 2003 Mar; 18(2):89-91. PubMed ID: 12711406
[TBL] [Abstract][Full Text] [Related]
12. Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study.
Pilhatsch M; Wolf R; Winter C; Lewitzka U; Bauer M
J Affect Disord; 2010 Nov; 126(3):453-7. PubMed ID: 20547424
[TBL] [Abstract][Full Text] [Related]
13. Focus on paroxetine.
Green B
Curr Med Res Opin; 2003; 19(1):13-21. PubMed ID: 12661775
[TBL] [Abstract][Full Text] [Related]
14. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
Weihs KL; Settle EC; Batey SR; Houser TL; Donahue RM; Ascher JA
J Clin Psychiatry; 2000 Mar; 61(3):196-202. PubMed ID: 10817105
[TBL] [Abstract][Full Text] [Related]
15. Paroxetine and amitriptyline in the treatment of depression in general practice.
Christiansen PE; Behnke K; Black CH; Ohrström JK; Bork-Rasmussen H; Nilsson J
Acta Psychiatr Scand; 1996 Mar; 93(3):158-63. PubMed ID: 8739658
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine treatment of trichotillomania in an adolescent.
Block C; West SA; Baharoglu B
J Child Adolesc Psychopharmacol; 1998; 8(1):69-71. PubMed ID: 9639081
[TBL] [Abstract][Full Text] [Related]
17. Economic appraisal of citalopram in the management of single-episode depression.
Sclar DA; Skaer TL; Robison LM; Galin RS
J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):47S-54S. PubMed ID: 10507508
[TBL] [Abstract][Full Text] [Related]
18. Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients.
Mamo DC; Sweet RA; Mulsant BH; Pollock BG; Miller MD; Stack JA; Begley AE; Reynolds CF
Am J Geriatr Psychiatry; 2000; 8(3):226-31. PubMed ID: 10910421
[TBL] [Abstract][Full Text] [Related]
19. Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial.
Braconnier A; Le Coent R; Cohen D;
J Am Acad Child Adolesc Psychiatry; 2003 Jan; 42(1):22-9. PubMed ID: 12500073
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
Trivedi MH; Pigotti TA; Perera P; Dillingham KE; Carfagno ML; Pitts CD
J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
